Ratings by Roth/MKM (Jonathan Aschoff)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/25/2025 | Pelthos Therapeutics | PTHS | New Coverage | Buy (N/A) |
25.40 (23.12) |
-8.98% | Details | |
| 12/2/2024 | GT Biopharma Inc. | GTBP | New Coverage | Buy (N/A) |
2.86 (0.47) |
-83.57% | Details | |
| 10/23/2024 | Cyclacel Pharmaceuticals | CYCC | Downgrade | Neutral (Buy) |
1.43 (6.37) |
345.45% | Details | |
| 10/7/2024 | Biofrontera | BFRI | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2024 | TFF Pharmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Aptevo Therapeutics | APVO | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Biofrontera | BFRI | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | BioRestorative Therapies Inc. | BRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2024 | GeoVax Labs Inc. | GOVX | New Coverage | Buy (N/A) |
2.78 (1.79) |
-35.61% | Details | |
| 6/27/2024 | BioRestorative Therapies Inc. | BRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Creative Medical Tech Holdings Inc. | CELZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Biofrontera | BFRI | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | BioRestorative Therapies Inc. | BRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Cyclacel Pharmaceuticals | CYCC | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | MindMed | MNMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Helius Medical Tech | HSDT | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Biofrontera | BFRI | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Panbella Therapeutics | PBLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2023 | OnTrak | OTRK | New Coverage | Buy (N/A) |
0.55 (0.33) |
-40% | Details | |
| 11/7/2023 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | Acer Therapeutics | ACER | Downgrade | Neutral (Buy) |
0.61 (0.90) |
47.54% | Details | |
| 6/13/2023 | Creative Medical Tech Holdings Inc. | CELZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Tenax Therapeutics | TENX | New Coverage | Buy (N/A) |
0.68 (10.69) |
1472.06% | Details | |
| 2/27/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | Immix Biopharma, Inc. | IMMX | New Coverage | Buy (N/A) |
2.07 (9.29) |
348.79% | Details | |
| 2/17/2023 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2023 | Clene, Inc. | CLNN | New Coverage | Buy (N/A) |
1.59 (5.36) |
237.11% | Details | |
| 1/31/2023 | Panbella Therapeutics | PBLA | New Coverage | Buy (N/A) |
1.53 (0.01) |
-99.35% | Details | |
| 12/9/2022 | MindMed | MNMD | New Coverage | Buy (N/A) |
2.66 (8.84) |
232.33% | Details | |
| 12/7/2022 | BioRestorative Therapies Inc. | BRTX | New Coverage | Buy (N/A) |
3.25 (0.21) |
-93.54% | Details | |
| 11/17/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2022 | Helius Medical Tech | HSDT | New Coverage | Buy (N/A) |
0.55 (2.19) |
298.18% | Details | |
| 8/15/2022 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Cyclacel Pharmaceuticals | CYCC | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2022 | Ocugen, Inc. | OCGN | New Coverage | Buy (Neutral) |
1.94 (1.61) |
-17.01% | Details | |
| 5/26/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | Ampio Pharmaceuticals | AMPE | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Creative Medical Tech Holdings Inc. | CELZ | New Coverage | Buy (N/A) |
1.83 (1.88) |
2.73% | Details | |
| 12/1/2021 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Biofrontera | BFRI | New Coverage | Buy (N/A) |
2.63 (0.86) |
-67.3% | Details | |
| 9/27/2021 | Seelos Therapeutics | SEEL | Upgrade | Buy (Neutral) |
2.09 (1.28) |
-38.76% | Details | |
| 6/11/2021 | Novan | NOVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2021 | Vascular Biogenics Ltd | VBLT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/17/2021 | Seelos Therapeutics | SEEL | Downgrade | Neutral (Buy) |
5.19 (2.09) |
-59.73% | Details | |
| 4/22/2021 | Novan | NOVN | New Coverage | Buy () |
1.17 (0.09) |
-92.31% | Details | |
| 4/1/2021 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Shoals Technologies Group | SHLS | New Coverage | Buy (N/A) |
35.85 (5.71) |
-84.07% | Details | |
| 3/4/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2021 | Applied DNA Sciences | APDN | New Coverage | Buy (N/A) |
12.57 (5.62) |
-55.29% | Details | |
| 2/1/2021 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2021 | Kempharm | KMPH | New Coverage | Buy (N/A) |
6.02 (5.81) |
-3.49% | Details | |
| 12/7/2020 | Acer Therapeutics | ACER | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Inovio Pharmaceuticals | INO | Downgrade | Sell (Neutral) |
12.85 (1.74) |
-86.46% | Details | |
| 11/10/2020 | Inovio Pharmaceuticals | INO | Upgrade | Neutral (Sell) |
10.53 (12.85) |
22.03% | Details | |
| 11/9/2020 | Aptevo Therapeutics | APVO | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Entasis Therapeutics | ETTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2020 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2020 | Inovio Pharmaceuticals | INO | Maintain | Sell (N/A) |
|
Details | ||
| 8/14/2020 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Inovio Pharmaceuticals | INO | Maintain | Sell (N/A) |
|
Details | ||
| 7/14/2020 | INmune Bio Inc. | INMB | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Entasis Therapeutics | ETTX | New Coverage | Buy (N/A) |
2.94 (2.19) |
-25.51% | Details | |
| 7/1/2020 | Inovio Pharmaceuticals | INO | Downgrade | Sell (Neutral) |
26.95 (1.74) |
-93.54% | Details | |
| 6/29/2020 | Acer Therapeutics | ACER | New Coverage | Buy (N/A) |
3.52 (0.90) |
-74.43% | Details | |
| 5/14/2020 | Eyenovia | EYEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Inovio Pharmaceuticals | INO | Maintain | Neutral (N/A) |
|
Details | ||
| 4/30/2020 | Inovio Pharmaceuticals | INO | Downgrade | Neutral (Buy) |
13.74 (1.74) |
-87.34% | Details | |
| 4/27/2020 | Cyclacel Pharmaceuticals | CYCC | New Coverage | Buy (N/A) |
4.02 (6.37) |
58.46% | Details | |
| 3/4/2020 | Aptevo Therapeutics | APVO | New Coverage | Buy (N/A) |
0.39 (6.40) |
1541.03% | Details | |
| 2/19/2020 | Aridis Pharmaceuticals | ARDS | New Coverage | Buy (N/A) |
6.15 (0.00) |
-100% | Details | |
| 1/27/2020 | Eyenovia | EYEN | New Coverage | Buy (N/A) |
4.21 (15.82) |
275.77% | Details | |
| 1/24/2020 | AzurRx Biopharma | AZRX | New Coverage | Buy (N/A) |
1.08 (3.45) |
219.44% | Details | |
| 12/19/2019 | Inovio Pharmaceuticals | INO | New Coverage | Buy (N/A) |
2.63 (13.74) |
422.43% | Details | |
| 12/19/2019 | INmune Bio Inc. | INMB | New Coverage | Buy (N/A) |
5.72 (1.33) |
-76.75% | Details | |
| 12/19/2019 | Ampio Pharmaceuticals | AMPE | New Coverage | Buy (N/A) |
0.41 (0.29) |
-29.27% | Details |
